COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention
Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque
Abstract
: Seeing the cardiovascular complications in COVID-19 patients and its association with the existing drug, risk-benefit ratio of treatment paradigm, as well as the level of cardiac injury biomarkers must be monitored regularly. Additionally, a well-designed clinical trial should be conducted where head to head comparison can be made with anti-COVID-19 drugs and cardioprotective anti-inflammatory drugs. Nevertheless, vaccines are the best-suited approach, but until then, sanitization, social distancing, and active lifestyle are the best ways to beat this global pandemic situation.
Topics & Concepts
Cytokine stormMedicineARDSIntensive care medicinePandemicCoronavirus disease 2019 (COVID-19)Clinical trialIntervention (counseling)Cytokine release syndromeAntiviral drugMechanism (biology)DrugBioinformaticsInternal medicineLungPharmacologyDiseaseBiologyEpistemologyPhilosophyInfectious disease (medical specialty)PsychiatryCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders